These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Metformin is associated with a lower risk of non-Hodgkin lymphoma in patients with type 2 diabetes. Tseng CH. Diabetes Metab; 2019 Oct; 45(5):458-464. PubMed ID: 31129317 [Abstract] [Full Text] [Related]
3. Metformin Use and Leukemia Risk in Patients With Type 2 Diabetes Mellitus. Tseng CH. Front Endocrinol (Lausanne); 2020 Oct; 11():541090. PubMed ID: 33193076 [Abstract] [Full Text] [Related]
14. Metformin use and cervical cancer risk in female patients with type 2 diabetes. Tseng CH. Oncotarget; 2016 Sep 13; 7(37):59548-59555. PubMed ID: 27486978 [Abstract] [Full Text] [Related]
15. Metformin Is Associated with a Lower Incidence of Benign Brain Tumors: A Retrospective Cohort Study in Patients with Type 2 Diabetes Mellitus. Tseng CH. Biomolecules; 2021 Sep 25; 11(10):. PubMed ID: 34680039 [Abstract] [Full Text] [Related]